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B I O C H E M I S T R Y
A nucleotidyltransferase toxin inhibits growth 
of Mycobacterium tuberculosis through inactivation 
of tRNA acceptor stems
Yiming Cai1*, Ben Usher2*, Claude Gutierrez3, Anastasia Tolcan4, Moise Mansour1,  
Peter C. Fineran5,6,7, Ciarán Condon4, Olivier Neyrolles3, Pierre Genevaux1†‡, Tim R. Blower2†‡
Toxin-antitoxin systems are widespread stress-responsive elements, many of whose functions remain largely 
unknown. Here, we characterize the four DUF1814-family nucleotidyltransferase-like toxins (MenT1–4) encoded 
by the human pathogen Mycobacterium tuberculosis. Toxin MenT3 inhibited growth of M. tuberculosis when not 
antagonized by its cognate antitoxin, MenA3. We solved the structures of toxins MenT3 and MenT4 to 1.6 and 1.2 Å 
resolution, respectively, and identified the biochemical activity and target of MenT3. MenT3 blocked in vitro 
protein expression and prevented tRNA charging in vivo. MenT3 added pyrimidines (C or U) to the 3′-CCA acceptor 
stems of uncharged tRNAs and exhibited strong substrate specificity in vitro, preferentially targeting tRNASer 
from among the 45 M. tuberculosis tRNAs. Our study identifies a previously unknown mechanism that expands the 
range of enzymatic activities used by bacterial toxins, uncovering a new way to block protein synthesis and 
potentially treat tuberculosis and other infections.
INTRODUCTION
Toxin-antitoxin (TA) systems are widely distributed throughout 
prokaryotic genomes and have been shown to help bacteria to survive 
predation by bacteriophages, immune responses, and antibiotic 
treatments (1–5). In many cases, however, the roles of chromosomal 
TA systems remain largely unknown, primarily due to the lack of a 
phenotype associated with deletion mutants under in vitro labora-
tory conditions (6–9). TA systems are also widespread among 
mobile genetic elements, including plasmids, superintegrons, cryptic 
prophages, and conjugative transposons, where they contribute to 
their stability (10, 11).
TA systems encode two components, a toxic protein that targets 
an essential cellular process and an antagonistic antitoxin, which 
blocks toxin activity when cells are growing under favorable condi-
tions. Although the processes that lead to toxin activation remain 
under debate, it has been proposed that under certain stress condi-
tions, increased toxin transcription and synthesis may lead to acti-
vation (8, 12). This, in turn, reduces growth rate, which can provide 
a means to survive with minimal metabolic burden until favorable 
conditions return (13).
TA systems are divided into six types according to the nature of 
the toxin and antitoxin (whether they are RNA or protein) and the 
mechanism of toxin antagonism (3). Type II systems, in which a 
protein toxin is sequestered by a protein antitoxin, have been 
most extensively studied. They are also remarkably abundant in 
Mycobacterium tuberculosis, which potentially encodes more than 
80 type II TA systems, and are thought to have contributed to the 
success of M. tuberculosis as a human pathogen (14–16). Many 
of the putative M. tuberculosis toxins tested thus far were shown 
to inhibit bacterial growth, suggesting that these TA systems are 
functionally active and could modulate M. tuberculosis growth 
under certain conditions, thereby contributing to survival in the 
human host (15, 17). Accordingly, many M. tuberculosis TA operons 
were shown to be induced in response to relevant stressors, includ-
ing hypoxia, the presence of antimicrobial drugs, or macrophage 
engulfment (14, 17). As M. tuberculosis encodes, among others, 
more than 50 VapBC, 10 MazEF, 3 HigBA, and 3 RelBE TA sys-
tems, it might be expected that there is redundancy between 
them, alongside condition-specific applications for each system. 
Furthermore, the highly toxic nature of some of these toxins suggests 
that their antibacterial mechanisms could be developed into anti-
microbials (18).
This study focuses on a family of four putative toxins from 
M. tuberculosis, namely, Rv0078A, Rv0836c, Rv1045, and Rv2826c, 
which share a conserved nucleotidyltransferase (NTase)–like domain 
annotated as domain of unknown function (DUF) 1814 (Fig. 1A). 
The most well-characterized example of this DUF1814 family is 
AbiEii from Streptococcus agalactiae, which shares 18.3% sequence 
identity with Rv1045, and was identified within the AbiE abortive 
infection bacteriophage-defense systems (19). AbiEii was shown to 
constitute a new type of TA system, type IV, based on the observa-
tion that no interaction could be detected between the toxin and the 
antitoxin proteins (20). The DUF1814 family of proteins is wide-
spread in bacterial, archaeal, and fungal genomes (20), though not 
all examples are genetically linked to putative antitoxins. As puta-
tive NTases, DUF1814 proteins contain four conserved motifs. The 
N-terminal motifs I and II are found in DNA polymerase  and are 
proposed to coordinate a metal ion for nucleotide binding and 
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Fig. 1. Analysis of the four TA systems with NTase-like toxins encoded by the M. tuberculosis genome. (A) Scaled representation of the four M. tuberculosis TA sys-
tems containing NTase-like toxin genes with original and revised nomenclature (left), and corresponding toxicity and antitoxicity assays in M. smegmatis (right). For 
toxicity and antitoxicity assays, cotransformants of M. smegmatis mc2 155 containing pGMC-vector, -MenT1, -MenT2, -MenT3, or -MenT4 (toxins) and pLAM- vector, 
-MenA1, -MenA2, -MenA3, or -MenA4 (antitoxins) were plated on LB-agar in the presence or absence of anhydrotetracycline (Atc; 100 ng ml−1) and acetamide (Ace; 0.2%) 
inducers for toxin and antitoxin expression, respectively. Plates were incubated for 3 days at 37°C. “T” and “A” denote toxin and antitoxin, respectively. “−” and “+” represent 
absence or presence of inducer, respectively. (B) M. smegmatis strain mc2 155 transformed with plasmid pGMCS-TetR-P1-RBS1-MenT3 was grown in complete 7H9 medium 
with Sm. At time 0, the culture was divided into two. Half was kept in the same medium (pale blue bars) and half was additionally treated with Atc (200 ng ml−1) (dark 
blue bars). Samples were harvested at the indicated times, washed, diluted, and plated on LB-agar with Sm but without Atc. Colonies were counted after 3 days at 
37°C. Shown values are the average of three biological replicates with SD. CFU, colony-forming unit. (C) Samples of the same cultures as in (B) were harvested after 8 or 
24 hours, labeled with the LIVE/DEAD BacLite dyes [Syto 9; propidium iodide (PI)], and analyzed by fluorescence-activated cell sorting. The percentage of PI-positive cells 
is shown for each sample (pale blue bars, no Atc; dark blue bars, 200 ng ml−1 Atc). Shown values are the average of three biological replicates with SD. (D) M. tuberculosis 
wild-type (WT) H37Rv or mutant strain H37Rv (menA3-menT3)::dif6 were transformed with 100 ng of plasmids expressing either menA3, menT3, or menA3-menT3. These 
plasmids encode a consensus Shine-Dalgarno sequence (RBS1), except for “Weak-RBS-menT3,” which encodes a near-consensus sequence (RBS4) to weaken expression. 
After phenotypic expression, half of the transformation mix was plated on 7H11 oleic acid–albumin-dextrose-catalase (OADC) plates with Sm, and the other half 
was plated on 7H11 OADC Sm plates supplemented with Atc (200 ng ml−1). Plates were imaged after 20 days at 37°C; data are representative of three independent 
experiments. (E) Mutant strain H37Rv (menA3-menT3)::dif6 was transformed with 100 ng of plasmids expressing either menT3 WT or mutant alleles introducing the 
D80A, K189A, or D211A substitutions. After phenotypic expression, half of the transformation mix was plated on 7H11 OADC plates with Sm, and the other half was plated 
on 7H11 OADC Sm plates supplemented with Atc (200 ng ml−1). Pictures were taken after 20 days at 37°C; data are representative of three independent experiments.
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transfer (20). The C-terminal motif III is similar to that of tRNA 
NTases that add the 3′-CCA motif to immature tRNAs and may be 
important for base stacking with substrates (21). The C-terminal 
motif IV is unique to DUF1814 proteins and is proposed to form a 
catalytic site with motif III (20).
In M. tuberculosis, the DUF1814 toxins are encoded downstream 
of a variety of putative antitoxins (Fig. 1A). The toxin gene rv0078A 
is paired with a short upstream open reading frame encoding a 68–
amino acid antitoxin, Rv0078B, related to MazE antitoxins, which is 
predicted to be disordered and lacking a DNA-binding domain 
(16). Toxin gene rv0836c lies downstream of a COG4861 gene, 
encoding a much larger putative antitoxin than the cognate toxin 
(Fig. 1A). Rv1045 and Rv2826c toxins are downstream of their 
cognate putative antitoxins Rv1044 and Rv2827c, respectively, both 
of which are COG5340 transcriptional regulator family proteins 
(Fig. 1A). COG5340 proteins include the S. agalactiae AbiEi anti-
toxin partner of AbiEii, which has previously been shown to bind to 
and repress the abiE promoter, similar to autoregulation observed 
in type II TA loci (22). An earlier transposon site hybridization 
study identified both the Rv1044 and Rv2827c antitoxins as essen-
tial for growth (23). Saturating transposon mutagenesis has addi-
tionally demonstrated that Rv1044 is essential, while transposon 
insertions in Rv2827c impart a growth defect (24). The fact that 
both antitoxins are important for M. tuberculosis growth strongly 
suggests that their putative cognate Rv1045 and Rv2826c toxins 
inhibit growth in M. tuberculosis.
Here, we undertook a series of microbiological, structural, 
genetic, and biochemical studies to investigate the DUF1814 toxins 
of M. tuberculosis and reveal their mode of action. We show that the 
Rv1045 toxin is a tRNA NTase that is active in M. tuberculosis and 
blocks translation through a previously undescribed mechanism 
involving inactivation of serine tRNAs.
RESULTS
Three DUF1814 proteins are part of bona fide TA systems
We first investigated the activity of the putative TA systems contain-
ing NTase-like DUF1814 toxins in Mycobacterium smegmatis, which 
is closely related to M. tuberculosis and does not encode similar anti-
toxins (15). On the basis of the findings presented below, we renamed 
these putative systems as “mycobacterial AbiE-like NTase toxins” 
(MenT) and antitoxins (MenA), numbered according to their order 
in the M. tuberculosis genome (Fig. 1A). Toxins and antitoxins were 
expressed in trans, with the toxins cloned into the pGMC-integrative 
plasmid under the control of an anhydrotetracycline (Atc)–inducible 
promoter and the antitoxins into the compatible pLAM plasmid 
under the control of an acetamide (Ace)–inducible promoter (Fig. 1A). 
Among the four putative toxins, only MenT1 has been tested so far 
and was shown to be toxic in M. smegmatis when expressed without 
the upstream open reading frame encoding MenA1, suggesting that 
MenA1-MenT1 form a functional TA system (16). Accordingly, the 
data presented in Fig. 1A show that MenT1 toxicity was efficiently 
counteracted by MenA1 expressed in trans. Both MenA3-MenT3 
and MenA4-MenT4 also acted as TA pairs, while MenT2 expression 
was not toxic (Fig. 1A). Inhibition of MenT4 toxicity could only be 
achieved when the putative antitoxin was expressed in the context 
of the menA4-menT4 operon (Fig. 1A). Expression of MenA4 alone 
from pLAM was toxic (fig. S1A), indicating that MenA4-MenT4 might 
not function as a typical TA pair under these conditions. Similar 
experiments performed in Escherichia coli confirmed the pheno-
types observed in M. smegmatis for MenA2-MenT2, MenA3-MenT3, 
and MenA4-MenT4 (including MenA4 toxicity), but not for MenT1, 
which exhibited no detectable toxicity in E. coli (fig. S1B). Last, co-
expression of the active toxins with noncognate antitoxins did not 
reveal any detectable cross-talk between the different TA pairs (fig. S1, 
A and C). Note that cross-talk assays with MenA4 antitoxin expressed 
from pLAM in M. smegmatis could not be performed because of 
its toxicity.
Ectopic expression of MenT3 in the presence of inducer showed 
the most robust toxicity in both M. smegmatis and E. coli when 
compared to the other toxins (Fig. 1A and fig. S1). In M. smegmatis, 
only a few MenT3 transformants were obtained, even in the absence 
of inducer. Ectopic expression of MenT3 in M. smegmatis induced a 
rapid drop of about 3-log10 in colony-forming units only 2 hours 
after induction with Atc (Fig. 1B). LIVE/DEAD BacLight stains 
have previously been used to study the effects of toxin expression on 
cell viability in M. tuberculosis (18). Flow cytometry analysis of 
M. smegmatis expressing MenT3 revealed that the proportion of 
propidium iodide–permeable cells was substantially higher in 
MenT3-induced versus noninduced cells 8 or 24 hours after induc-
tion with Atc (Fig. 1C), indicating that MenT3 strongly affects 
cell viability.
MenA3-MenT3 is a functional TA system in M. tuberculosis
To investigate the impact of MenA3 and MenT3 on M. tuberculosis 
growth, plasmids encoding the toxin, the antitoxin, or both, were 
introduced into H37Rv wild-type (WT) strain. The resulting 
transformants were not sensitive to ectopic expression of MenT3 
(Fig. 1D), presumably because endogenous MenA3 was sufficient to 
neutralize the sum of endogenous and ectopic MenT3. To confirm 
this hypothesis, we attempted to construct a strain deleted for the 
menA3-menT3 operon. Previous work showed that menA3 cannot 
be disrupted by transposon insertion (24). Accordingly, we found 
that deletion of the menA3-menT3 operon in M. tuberculosis H37Rv 
strain could not be achieved, most likely because simultaneous 
disruption of both genes resulted in a toxic effect from residual MenT3. 
To circumvent this problem, we constructed the deletion in a deriv-
ative of H37Rv carrying a second copy of menA3 constitutively 
expressed from a pGMC integrative plasmid. Once the menA3-menT3 
operon was deleted, it was then possible to remove the ectopic copy 
of menA3 by pGMC plasmid replacement (fig. S2). The ∆menA3- 
menT3 mutant became highly sensitive to the MenT3 toxin, even in 
the absence of inducer (Fig. 1D). Therefore, to finally obtain trans-
formants, menT3 was cloned downstream of a weaker Shine-Dalgarno 
sequence. Using this construct, we observed inducible MenT3 toxicity, 
which was fully abolished by the presence of the antitoxin (Fig. 1D). 
Together, these data demonstrate that the MenT3 toxin inhibits 
growth and that MenA3-MenT3 functions as a bona fide TA pair in 
M. tuberculosis.
A previous amino acid sequence alignment of DUF1814 putative 
NTases highlighted conserved residues, a number of which were confirmed 
as essential for AbiEii toxicity in S. agalactiae (20). To investigate whether 
some of these residues were important for MenT3 toxicity, we selected 
and engineered three conserved residues for substitution: D80A, localized 
in the DNA pol superfamily motif, and K189A and D211A, both toxin- 
specific residues. We then tested the impact of these substitutions on 
M. tuberculosis growth (Fig. 1E). All three substitutions abolished MenT3 
toxicity in both M. tuberculosis (Fig. 1E) and E. coli (fig. S3A).
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Next, we investigated whether the MenT3 toxin and MenA3 
antitoxin could interact in vivo. Since this TA pair is functional in 
E. coli, we performed affinity-tagged in vivo copurification experi-
ments in E. coli using His-tagged variants of MenT3 and MenA3, 
which were first confirmed to be active as toxin and antitoxin, 
respectively (fig. S4A). In strains coexpressing both the toxin and 
the antitoxin (with either the toxin or the antitoxin tagged), and 
with tagged toxin and tagged antitoxin alone as controls, the in vivo 
copurification revealed that a small but significant fraction of the 
MenT3 toxin and the MenA3 antitoxin copurified, whether the 
toxin or the antitoxin was used as bait (fig. S4, C and D). Similar 
results were obtained with the MenA1-MenT1 pair, which encodes a 
much shorter, unrelated antitoxin (fig. S4, B, E, and F). Together, 
these data show that both TA partners can interact, but it remains 
to be determined whether a direct interaction between an NTase 
toxin and its cognate antitoxin is required for toxin inhibition.
MenT3 and MenT4 are structural homologs
To begin investigations into the mechanism of toxicity of MenT3, 
we solved its structure to 1.6 Å resolution by x-ray crystallography 
(Fig. 2A and Table 1). MenT3 is a monomeric bi-lobed globular 
protein, with two hemispheres connected by a short linker (Fig. 2A). 
This monomeric assembly matches the expected size observed by 
size exclusion chromatography. Surface electrostatics show a dis-
tinct electropositive surface leading to a deeper recess (Fig. 2B, left), 
which contains residues D80, K189, and D211 that were needed for 
toxicity in vivo (Fig. 1E). This potentially indicates the position of 
the active site, and the electropositive surface may facilitate interac-
tion with electronegative substrates such as nucleic acids. To further 
characterize the DUF1814 family, we also solved the MenT4 toxin 
structure to 1.2 Å resolution (Fig. 2C and Table 1). MenT4 is also 
monomeric (also observed by size exclusion chromatography) and 
the overall architecture is similar to, but not exactly the same as, 
MenT3. MenT4 has a bi-lobed globular structure and distinct elec-
tropositive patches close to a similarly positioned active site region 
(Fig. 2, C and D). Aligning MenT3 and MenT4 by sequence gave a 
poor root mean square deviation (RMSD) of 13.4 Å; however, this 
can be improved to 4.7 Å using sequence-independent super-
position, which demonstrates similarity in overall fold (Fig. 2E). 
A close-up of MenT3 residues D80, K189, and D211 show them 
Fig. 2. Crystal structure of the MenT3 and MenT4 toxins. (A) Structure of monomeric MenT3 toxin, with views from front and back, shown as cyan cartoon represent-
ations. (B) Surface electrostatics of MenT3, viewed as in (A), with red for electronegative and blue for electropositive potential. (C) Structure of monomeric MenT4, with 
views from front and back, shown as salmon cartoon representations. (D) Surface electrostatics of MenT4, viewed as in (C), colored as per (B). (E) Superposition of MenT4 
onto MenT3, viewed and colored as per (A) and (C). (F) Tilted close-up view of the toxin active sites, as indicated by the boxed region of (E). MenT3 residues S78 (phosphorylated), 
D80, K189, and D211 are indicated, along with the homologous MenT4 residues S67, D69, K171, and D186. (G) Alignment of JHP933 (PDB: 4O8S) as orange cartoon repre-
sentation, against MenT3 viewed and colored as per (A, left).
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clustered at the putative active site, and when overlaid, the homo-
logous MenT4 residues, D69, K171, and D186, respectively, take up 
similar positions (Fig. 2F). There was also density for a phospho-
serine at MenT3 S78, but the corresponding residue in MenT4, S67, 
was not phosphorylated (Fig. 2F). Searches for structural homologs 
of MenT3 and MenT4 were performed using the DALI server (25). 
Among multiple hits for NTases, the best match was for JHP933 
from Helicobacter pylori, a predicted NTase encoded by the jhp0933 
gene (26). JHP933 aligned to MenT3 with an RMSD of 2.4 Å, though 
multiple additional helices were resolved in the MenT3 struc-
ture (Fig. 2G). An analysis of the H. pylori genome revealed that 
the jhp0932 gene lies just upstream of jhp0933 and partially over-
laps its coding sequence. The presence of these genes in what appears 
to be a classic TA configuration suggests that JHP933 may belong to 
the MenT3/MenT4 family of NTase-like toxins.
RNase PH overexpression confers resistance to MenT3
MenT3 is the most toxic of the four M. tuberculosis NTase-like toxins 
tested, both in mycobacteria and in E. coli (Fig. 1 and fig. S1). We 
therefore took advantage of this robust toxicity to search for E. coli 
genes that were able to suppress MenT3-mediated growth inhibition 
when overexpressed. We reasoned that identification of such 
Table 1. Crystallographic data collection and refinement statistics.  
MenT3 native MenT3 Se-peak MenT3 Se-high remote MenT3 Se-inflection MenT4 native
Data collection
PDB ID code 6Y5U - - - 6Y56
Beamline Diamond I04 Diamond I03 Diamond I03 Diamond I03 Diamond I24
Wavelength (Å) 0.9795 0.9793 0.9641 0.9795 0.9781
Resolution range (Å) 47.70–1.59 (1.65–1.59)* 47.78–2.19 (2.26–2.19) 47.83–2.05 (2.11–2.05) 53.13–2.04 (2.11–2.04) 42.23–1.23 (1.27–1.23)
Space group P3221 P3221 P3221 P3221 P21
Unit cell, a b c (Å),    (°)
95.4 95.4 69.0, 90.0 90.0 
120.0
95.6 95.6 69.2, 90.0 90.0 
120.0
95.7 95.7 69.3, 90.0 90.0 
120.0
95.6 95.6 69.3, 90.0 90.0 
120.0
42.3 57.8 54.7, 90.0 92.3 
90.0
Total reflections 98,016 (9668) 36,407 (3179) 44,514 (3476) 47,255 (4637) 149,653
Unique reflections 49,008 (4834) 19,130 (1646) 23,313 (1788) 23,628 (2319) 75,996 (7206)
Multiplicity 2.0 1.9 1.9 2.0 2.0
Completeness (%) 99.95 (99.83) 100.00 (100.00) 100.00 (99.80) 100.00 (99.70) 98.80 (88.97)
Mean I/(I) 16.7 6.5 7.6 8.9 7.0
Rmerge 0.016 (0.486) 0.055 (0.373) 0.055 (0.522) 0.048 (0.463) 0.060 (0.926)
Rmeas 0.022 (0.687) 0.077 (0.528) 0.078 (0.739) 0.068 (0.654) 0.085 (1.310)
CC1/2 1.0 (0.672) 0.995 (0.803) 0.997 (0.544) 0.997 (0.641) 0.996 (0.294)
Refinement
Rwork 0.2024 (0.2924) - - - 0.1840 (0.3174)
Rfree 0.2242 (0.3108) - - - 0.1950 (0.3352)
No. of non-hydrogen 
atoms 2494 - - - 2649
Macromolecules 2213 - - - 2322
Solvent 281 - - - 327
Protein residues 288 - - - 292
RMSD (bonds, Å) 0.006 - - - 0.005
RMSD (angles, °) 0.940 - - - 0.830
Ramachandran favored 
(%) 97.53 - - - 98.28
Ramachandran allowed 
(%) 2.47 - - - 1.72
Ramachandran outliers 
(%) 0.00 - - - 0.00
Average B factor 34.1 - - - 20.6
Macromolecules 33.4 - - - 19.3
Solvent 39.4 - - - 29.9
 *Statistics for the highest-resolution shell are shown in parentheses.
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Fig. 3. RNase PH suppresses MenT3 toxicity and inhibition of translation. (A) The E. coli K-12 genomic region containing the rph gene is shown. Suppressor 
plasmids that counteract MenT3 toxicity encoded rph, as depicted by small arrows under the adjacent genes pyrE, yicC, and dinD. The positions in base pair of the ends 
of each suppressor fragment, in relation to the E. coli K-12 chromosome, are indicated between brackets. (B) Overexpression of E. coli RNase PH partially suppresses MenT3 
toxicity. E. coli DLT1900 strains containing either pK6-vector (−) or pK6-MenT3 (+) were cotransformed with p29SEN-vector (−) or p29SEN-Rph (RNase PH) (+). The resulting 
cotransformants were serially diluted, spotted onto LB-agar plates in the presence or absence of l-ara (0.1%) and IPTG (200 M) inducers, and incubated at 37°C. (C) Dele-
tion of rph further increases MenT3 toxicity. Transformants of E. coli DLT1900 WT and ∆rph mutant strains containing plasmid pK6-MenT3 were serially diluted, spotted 
onto LB-agar plates with or without l-ara (0.01%), and incubated at 37°C. (D) In vitro transcription/translation reactions assessing levels of DHFR control protein produced 
in the absence or presence of increasing concentrations of MenT3 toxin. Samples were separated by SDS–polyacrylamide gel electrophoresis and stained with InstantBlue. 
(E) For in vivo assays, transformants of E. coli BL21 (DE3) containing plasmid pET-MenT3 or the empty vector were grown in M9M at 37°C. Following overexpression of 
MenT3, tRNAs were extracted, separated, and visualized by Northern blot using specific radiolabeled probes against tRNATrp. For in vitro assays, purified MenT3 (10 M) 
was added to transcription/translation assays producing GatZ protein. After 2 hours at 37°C, tRNAs were extracted, separated, and visualized by Northern blot as performed 
for the in vivo samples. All images are representative of triplicate data.
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suppressors might potentially shed light on the cellular processes 
affected by the toxin. Details of the genetic selection used are described 
in Materials and Methods. Among the approximately 60,000 clones 
of the E. coli genomic plasmid library tested in this work, we identi-
fied 18 plasmids that passed two rounds of selection and appeared to 
encode bona fide suppressors of MenT3 toxicity. We observed that 
the toxin-resistant colonies were noticeably smaller and translucent 
compared to noninduced cells, indicating that, although notably 
reduced, MenT3 toxicity is not fully suppressed. Sequencing of the 
genomic regions encoded by the 18 suppressor plasmids revealed 
that several of these candidate plasmids harbored the same genomic 
fragments. Six different suppressor clones encompassing two different 
regions of the E. coli chromosome were identified. Two of the six 
suppressor plasmids harbored the ydeA gene, encoding an l-arabinose 
(l-ara) exporter protein known to decrease l-ara levels in E. coli 
(27). These suppressors were discarded as YdeA overexpression 
would presumably decrease toxicity of many toxic proteins 
expressed from the araBAD promoter. The four other suppressor plas-
mids harbored the rph gene, encoding the phosphorolytic ribonuclease 
(RNase PH), involved in the 3′ processing of RNAs (Fig. 3A). RNase 
PH removes nucleotides downstream of the 3′-CCA sequence, re-
quired for amino acylation of tRNAs, from tRNA precursors with 3′ 
extensions. It is also involved in other RNA maturation and quality 
control processes, including the maturation of rRNA (28).
Suppression of MenT3 toxicity by RNase PH overexpression was 
confirmed by cloning rph alone in a low–copy number plasmid under 
the control of an isopropyl--d-thiogalactopyranoside (IPTG)–
inducible promoter and assaying for growth in the presence of 
MenT3 in E. coli (Fig. 3B). We also showed that the toxicity of MenT3 
was enhanced when expressed in E. coli carrying a deletion of the 
rph gene, even with a 10-fold decrease in inducer levels (Fig. 3C), 
further reinforcing the genetic link between menT3 and rph. The 
primary role of RNase PH in processing tRNAs suggests that 
DUF1814 NTase-like toxins could act directly at the site of amino-
acylation at the 3′-end of tRNA, thus inhibiting translation. Whether 
endogenous RNase PH would be sufficiently induced in response to 
toxin expression to help restore the functional tRNA pool in recover-
ing M. tuberculosis cells remains to be determined.
MenT3 inhibits tRNA charging
MenT3 WT and the MenT3(D80A) and MenT3(K189A) substitutions 
were overexpressed and purified for biochemical characterization. 
When tested in an in vitro transcription/translation reaction that 
uses recombinant E. coli components, purified MenT3 WT reduced 
production of the E. coli dihydrofolate reductase (DHFR) control 
protein in a concentration-dependent manner (Fig. 3D). Compared 
to MenT3 WT, MenT3(D80A) and MenT3(K189A) had a markedly re-
duced impact on the production of DHFR (fig. S5A). The same trend 
was observed when MenT3 WT, MenT3(D80A), and MenT3(K189A) were 
used in in vitro reactions producing WaaF and GatZ as test proteins 
(fig. S5, B and C). We also expressed and purified MenT4 WT and 
demonstrated that this, too, prevented the production of DHFR 
in a concentration-dependent manner in in vitro transcription/
translation assays (fig. S5D).
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Fig. 4. Toxin MenT3 adds pyrimidines to the 3′-CCA acceptor stem of tRNA. (A) Radiolabeled E. coli tRNATrp was incubated with 1, 0.1, 0.01, or 0.001 g of MenT3 WT 
or no toxin (−) for 20 min at 37°C in the presence of unlabeled GTP, ATP, UTP, or CTP. Extended products are indicated with arrowheads throughout all panels. (B) Radio-
labeled E. coli tRNATrp was incubated with 1, 0.1, or 0.01 g of MenT3 WT or MenT3(D80A) with CTP or UTP, as per conditions in (A). (C) Incubation of radiolabeled E. coli 
tRNATrp with 1, 0.1, 0.01, or 0.001 g of MenT3 WT or MenT3(K189A), with CTP, UTP, or a mixture of both, as per conditions in (A). (D) Radiolabeled E. coli tRNATrp preparations, 
made with or without a 3′-CCA motif, were incubated with 1, 0.1, or 0.01 g of either MenT3 WT, MenT3(K189A), or no toxin (−), for 20 min at 37°C in the presence of unlabeled 
UTP or CTP. Note that the (−) CCA lanes have been overexposed to equalize intensity to the (+) CCA lanes of the same gel. Assays of the individual WT and MenT3 sub-
stitution proteins and tRNATrp ± CCA substrates shown in (A) to (D) were performed between two and four times.
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The fact that MenT3 inhibited protein synthesis, and that RNase 
PH is involved in the removal of nucleotides following the 3′-CCA 
sequence required for tRNA aminoacylation, suggested that tRNA 
charging might be affected by MenT3 expression in vivo. To address 
this hypothesis, we first used a method developed for E. coli, which 
separates charged from uncharged tRNAs and allows their detection 
by Northern blot after extraction in vivo (29). We chose tRNATrp as a 
model tRNA because (i) the tryptophanyl-tRNA can be well separated 
from uncharged tRNATrp and (ii) there is only one tRNATrp in E. coli 
(29). No charged tryptophanyl-tRNATrp could be detected following 
overexpression of MenT3 when compared to the empty vector control 
(Fig. 3E and fig. S5E). tRNATrp charging levels were also investigated 
in vitro by adding purified MenT3 to the transcription/translation assay 
described above (Fig. 3E). In this case, MenT3 also affected tRNATrp 
charging in vitro, thus supporting the hypothesis that the toxin in-
hibits protein synthesis by preventing aminoacylation of tRNA.
MenT3 transfers pyrimidines to the 3′ acceptor stem 
of specific tRNAs
The observation that MenT3 is related to NTases (Fig. 2G) suggests 
that its mode of action is to directly transfer nucleotides to tRNAs, 
thereby preventing aminoacylation. We performed assays using 
Arg-1 Arg-2 Arg-3 Arg-4 Ala-1 Ala-2 Ala-3 Leu-1 Leu-2 Leu-3 Leu-4 Leu-5 Ile Asp Asn
- + - + - + - + - + - + - + - + - + - + - + - + - + - + - + MenT3
Ser-1 Ser-2 Ser-3 Ser-4 Pro-1 Pro-2 Pro-3 Gly-1 Gly-2 Gly-3 Glu-1 Glu-2 Gln-1 Gln-2 Trp
MenT3
EcTrp
- +- + - + - + - + - + - + - + - + - + - + - + - + - + - + - +
Thr-1 Thr-2 Thr-3 Lys-1 Lys-2 Val-1 Val-2 Val-3 Met-1 Met-2 Met-3 Cys His Tyr Phe





elongation of 3′-CCA motif 
prevents tRNA charging
Interference with translation 












tRNA charging with 
cognate amino acid
-
Fig. 5. Screening for MenT3 M. tuberculosis tRNA targets. (A) Radiolabeled M. tuberculosis tRNAs were incubated with 0.1 g of MenT3 WT (+) or no toxin (−) for 20 min 
at 37°C in the presence of unlabeled CTP. E. coli tRNATrp (EcTrp) was used as a positive control. The global screen of all M. tuberculosis tRNA was performed once and the 
effect of MenT3 tRNASer2 was confirmed twice independently. (B) Schematic diagram of the MenT3 toxin mechanism of action. MenT3 elongates the 3′-CCA motif of spe-
cific tRNAs, preventing their charging by aminoacyl-tRNA synthetases (AaRS), thereby interfering with translation and inhibiting bacterial growth.
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radiolabeled tRNAs to track the addition of nucleotides by MenT3 
WT, MenT3(D80A), and MenT3(K189A) (Fig. 4).
MenT3 WT was incubated with tRNATrp from E. coli, as a model 
recipient tRNA, in the presence of guanosine 5′-triphosphate (GTP), 
adenosine 5′-triphosphate (ATP), uridine 5′-triphosphate (UTP), or 
cytidine 5′-triphosphate (CTP), and nucleotide transfer was moni-
tored as an increase in tRNA size by high-resolution polyacrylamide 
gel electrophoresis (PAGE; Fig. 4A). At high concentrations of the 
enzyme, we found that MenT3 can add two to three extra nucleo-
tides to tRNATrp in the presence of CTP or UTP, with a slight 
preference for CTP, suggesting that MenT3 is a pyrimidine-specific 
NTase (Fig. 4A). No transfer was observed with purines ATP or 
GTP as substrates (Fig. 4A). MenT3(D80A), which was unable to 
inhibit in vitro protein synthesis (fig. S5, A to C), had no NTase 
activity with either UTP or CTP (Fig. 4B). MenT3(K189A), which was 
also inactive in the in vitro transcription/translation assay (fig. S5, 
A to C), only lost its NTase activity in the presence of UTP, but 
retained some activity (albeit less than WT) in the presence of CTP, 
or both nucleotides (Fig. 4C). This could imply that K189A is 
important for substrate nucleotide selectivity. No synergistic effect 
was seen when MenT3 WT was incubated with a mixture of CTP 
and UTP, as the pattern with both nucleotides together resembled 
that of CTP alone (Fig. 4C).
Canonical tRNA NTases typically add the 3′-CCA motif to tRNAs 
lacking an encoded 3′-CCA that are processed at the level of the 
discriminator nucleotide (nucleotide 73). They also repair this 
motif when 3′-exoribonucleases, such as RNase PH, fail to stop at 
the 3′-CCA motif when processing tRNA precursors containing an 
encoded 3′-CCA, typically removing the terminal A residue. Since 
M. tuberculosis contains a mixture of tRNA genes encoding or lack-
ing a 3′-CCA motif, we wondered whether MenT3 had a preference 
for one class (or another class) of substrate. While faint NTase 
activity was observed when MenT3 WT and MenT3(K189A) were in-
cubated with CTP and tRNATrp lacking a 3′-CCA, the data show 
that MenT3 had a clear preference for tRNAs that already possessed 
a 3′-CCA motif (Fig. 4D). This is in contrast to the normal function 
of tRNA NTases, which prefer tRNAs lacking an intact 3′-CCA. 
Again, MenT3 WT modified tRNATrp using both CTP and UTP as 
substrate, while MenT3(K189A) could only use CTP (Fig. 4D). Addi-
tion of nucleotides to mature tRNAs by MenT3 would completely 
abolish the ability of these tRNAs to be charged with their cognate 
amino acid and take part in translation, accounting for their cellular 
toxicity.
Our in vivo data show that toxins MenT3, as well as MenT1 and 
MenT4, are significantly less toxic in E. coli than in mycobacteria 
(Fig. 1 and fig. S1), which suggests that these toxins may have a 
tRNA target preference. We therefore asked whether MenT3 would 
exhibit some specificity toward the different tRNAs of M. tuberculosis. 
We made polymerase chain reaction (PCR) templates allowing us 
to in vitro transcribe the 45 different tRNAs of M. tuberculosis, each 
with a 3′-CCA motif (fig. S6). As before, each radiolabeled tRNA 
was incubated with MenT3 and nonradiolabeled CTP (Fig. 5A). To 
our surprise, MenT3 appeared to be highly specific, preferentially 
modifying the four M. tuberculosis tRNASer isoacceptors, along with 
weak modification of tRNALeu5 (Fig. 5A). Although we cannot 
exclude that MenT3 can modify other tRNAs in vivo, the data show 
that the toxin presents a high degree of specificity toward different 
tRNAs in vitro, which may explain the variable toxicity observed in 
different bacteria.
Last, we asked whether the antitoxin MenA3 inhibited the NTase 
activity of MenT3 directly, or whether it could simply reverse its 
action by removing the added nucleotides in a manner similar to the 
RNase PH multicopy suppressor. Addition of MenA3 strongly inhibited 
the NTase activity of MenT3 on the natural substrate M. tuberculosis 
tRNASer2 when coincubated with the toxin at a molar ratio > 2.5. How-
ever, MenA3 failed to remove the added nucleotides from tRNASer2 
when added after a preincubation of tRNASer2 with MenT3, even at high 
concentrations (fig. S7). This suggests that the antitoxin is likely to 
inhibit the toxin rather than reverse the reaction on the substrate.
DISCUSSION
This study has characterized a family of TA systems from M. tuberculosis 
containing NTase-like DUF1814 toxins, establishing MenT3 as a 
potent toxin in this problematic pathogen. We have solved the 
structures of the homologous toxins MenT3 and MenT4 by x-ray 
crystallography, revealing fold similarity and conserved residues 
within the proposed active sites, and have observed a similar mode 
of toxin activity, targeting protein synthesis. We have further elucidated 
the mechanism of toxicity for MenT3, showing that it functions as a 
pyrimidine-specific NTase preferentially targeting M. tuberculosis 
tRNASer in vitro (Fig. 5B).
The observation that the three NTase toxins identified in this 
work show different levels of toxicity when expressed in the same 
host, and that such toxic signatures can vary when expressed in dif-
ferent bacterial hosts (i.e., E. coli versus mycobacteria), is intriguing 
(Fig. 1 and fig. S1). The most marked example is MenT1, which shows 
robust toxicity in M. smegmatis but no toxicity in E. coli (Fig. 1A 
and fig. S1B). Although we cannot exclude this being a result of 
improper folding or expression of the toxin in E. coli, it is also rea-
sonable to assume that the toxin may not be able to recognize its 
tRNA targets due, for example, to tRNA modification, or the absence 
of its preferred tRNA target (30). Another possibility is that tRNA 
targets are expressed at higher levels in E. coli and are thus sufficiently 
abundant to overcome the noxious effect of the toxin in vivo. The 
fact that M. tuberculosis and M. smegmatis only have 45 and 46 tRNA 
genes, respectively, while E. coli has 86, is in line with this hypo-
thesis (30, 31).
The apparent in vitro specificity of MenT3 for certain M. tuberculosis 
tRNAs, especially tRNASer, is remarkable (Fig. 5A). We did not test 
other tRNAs in E. coli besides tRNATrp; it may well have been fortuitous 
that the only tRNA we tested in this organism was detectably modified 
by the toxin in vitro (Fig. 4A) and in vivo, inferred from the reduced 
charging levels following toxin expression (Fig. 3E). We checked 
whether the M. tuberculosis tRNAs that were substrates of MenT3 
had any distinguishing features and were struck by the fact that all 
serine tRNAs and several leucine tRNAs were unique among 
M. tuberculosis tRNAs in that they had long variable arms (fig. S8A) 
(32). While this is intriguing and may contribute to substrate speci-
ficity, it cannot be the only recognition element because (i) two leucine 
tRNAs besides tRNALeu5 have variable loops but are not MenT3 
substrates in vitro and (ii) E. coli tRNATrp does not have a variable 
loop (fig. S8B), but can be extended by the NTase activity of the toxin. 
It is also intriguing in this regard that M. tuberculosis tRNATrp is not 
a MenT3 substrate in vitro. E. coli and M. tuberculosis tRNATrp are 
highly homologous but do show differences in their variable- and 
T-arm sequences (fig. S8C). Substrate specificity therefore appears 
to come from a combination of multiple sequence and structure 
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motifs. Having identified these tRNA targets in vitro, further work 
is now needed to confirm targeting in vivo in M. tuberculosis.
Our observed TA interactions raise questions regarding the 
molecular mechanisms of antitoxicity for DUF1814 toxins (fig. S4, 
C to F). Typically, in type II TA systems, antitoxin function is in part 
driven by its strong and direct interaction with the cognate toxin (3). 
While we have shown interactions between cognate toxins and 
antitoxins (fig. S4, C to F), the antitoxin interaction in vivo appears 
weak. We additionally demonstrated that coincubation of the MenA3 
antitoxin with MenT3 is able to neutralize the NTase activity (fig. S7). 
This suggests that any interaction-based antitoxicity might be a tran-
sient and labile mechanism and, due to the difference in size and 
sequence between antitoxins MenA1 and MenA3 (Fig. 1A), may well 
differ between these systems.
The DUF4433 DarT toxin from M. tuberculosis was recently 
identified as a single-stranded DNA NTase that specifically and 
reversibly adenosine 5′-diphosphate (ADP)–ribosylates thymidines 
(33). Our study identifies MenT3 as an NTase toxin from the unrelated 
DUF1814 protein family. In comparison to DarT, MenT3 acts via 
a distinct and novel mode of toxicity where the MenT3 toxin prefer-
entially targets M. tuberculosis tRNAs in vitro, preventing their 
charging with cognate amino acids by adding nucleotides to the 
3′-CCA acceptor stem (Fig. 5B). Accordingly, antitoxin function 
also appears to differ between these systems. Whereas DarT is 
counteracted enzymatically by the cognate antitoxin DarG via 
target de-ADP- ribosylation (33), we found that MenA3 was unable 
to reverse MenT3 toxicity by removing nucleotides, suggesting that 
MenA3 likely inhibits the toxin activity.
Increasing numbers of toxins have been identified that target 
tRNAs by various mechanisms (13). The M. tuberculosis type II 
VapC toxins function as endoribonucleases cleaving tRNAs (34), 
whereas TacT from Salmonella Typhimurium and AtaT from E. coli 
are tRNA acetyltransferases, modifying charged tRNAs to block 
translation (35, 36). That MenT3 provides yet another way to inhibit 
tRNA activity is perhaps not unusual, given the essential nature of 
translation to cellular growth and survival. This likely reflects the 
value of possessing multiple TA systems to promote adaptability to 
different stressful environments via tRNA metabolism, with down-
stream effects ranging from stalling cell growth to potentially altering 
translation output (13). It remains to be seen whether this mecha-
nism is conserved among DUF1814-toxins; while MenT4 shares 
structural similarities to MenT3 and inhibits protein synthesis in vitro 
(Fig. 2 and fig. S5D), we have not yet explored the molecular mech-
anism behind its toxicity. Given the continued significance of 
M. tuberculosis worldwide, the mechanism used by the MenA3-MenT3 
TA system highlights a new way to block protein synthesis. We pro-
pose that further exploring the molecular mechanisms of both 
toxicity and antitoxicity will provide useful insights into the regula-
tion of bacterial growth.
MATERIALS AND METHODS
Bacterial strains and culture conditions
E. coli DH5 (Invitrogen), DH10B (Thermo Fisher Scientific), BL21 
(DE3) (Novagen), ER2566 (New England Biolabs), W3110 [strain 
American Type Culture Collection (ATCC) 27325], DLT1900 (37), 
and M. smegmatis mc2 155 (strain ATCC 700084) are as previously 
described. To construct BL21 (DE3) ∆slyD, the ∆slyD::KmR allele 
from JW3311 (Keio collection) was moved into BL21 (DE3) using 
bacteriophage P1-mediated transduction. To construct the unmarked 
DLT1900 ∆rph mutant, the ∆rph::KmR allele from JW3618 (Keio 
collection) was first moved into DLT1900 using bacteriophage 
P1-mediated transduction and by subsequent removing of the 
kanamycin (Km) resistance cassette using plasmid pCP20, as previously 
described (38). E. coli were routinely grown at 37°C in LB medium 
or M9 minimal (M9M) medium supplemented when necessary 
with Km (50 g ml−1), ampicillin (Ap; 50 g ml−1), chloramphenicol 
(Cm; 34 g ml−1), streptomycin (Sm; 25 g ml−1), spectinomycin 
(Sp; 50 g ml−1), IPTG (1 mM), l-ara (0.1% w/v), or d-glucose (glu; 
0.2% w/v). M. smegmatis mc2 155 strains were routinely grown at 
37°C in either LB or 7H9 medium (Difco). M. tuberculosis H37Rv 
(WT; ATCC 27294) and mutant strains were routinely grown at 
37°C in complete 7H9 medium (Middlebrook 7H9 medium, Difco) 
supplemented with 10% albumin-dextrose-catalase (ADC; Difco) 
and 0.05% Tween 80 (Sigma-Aldrich), or on complete 7H11 solid 
medium (Middlebrook 7H11 agar medium, Difco) supplemented 
with 10% oleic acid–ADC (OADC; Difco). When required, myco-
bacterial growth media were supplemented with Km (50 g ml−1), 
hygromycin (Hm; 50 g ml−1), Sm (25 g ml−1), zeocin (Zc; 25 g ml−1), 
Ace (0.2% w/v), or Atc (100 or 200 ng ml−1).
Plasmid constructs
Plasmids pMPMK6 (39), p29SEN (40), pGMCS (41), pGMCZ (42), 
pLAM12 (43), pETDuet-1, pET15b and pRARE (Novagen), pBAD30 
(44), and pTA100 (4) have been described. Primers used for plasmid 
construction are described in table S1. All the plasmids constructed 
in this work have been verified by sequencing. The pMPMK6 derivatives 
expressing the toxins, namely, pK6-MenT1, pK6-MenT2, pK6-MenT3, 
and pK6-MenT4, were constructed as follows: menT1, menT2, menT3, 
and menT4 were PCR-amplified from the M. tuberculosis H37Rv 
genome and cloned as Eco RI/Hind III fragments (menT1 and menT2) 
and Mfe I/Hind III fragments (menT3 and menT4) into Eco RI/
Hind III–digested pMPMK6.
The p29SEN plasmid derivatives encoding the antitoxins, namely, 
p29SEN-MenA1, p29SEN-MenA2, p29SEN-MenA3, and p29SEN-MenA4, 
were constructed as follows: menA1, menA2, menA3, and menA4 were 
PCR-amplified from the M. tuberculosis H37Rv genome and cloned 
either as Eco RI/Hind III fragments (menA1, menA2, and menA3) or 
as Mfe I/Hind III fragments (menA4) into Eco RI/Hind III–digested 
p29SEN. For p29SEN-Rph, the rph gene was PCR-amplified from 
the E. coli DLT1900 genome and cloned as an Eco RI/Hind III fragment 
into Eco RI/Hind III–digested p29SEN.
To construct pGMC-MenT2, pGMC-MenT3, and pGMC-MenT4, 
menT2, menT3, and menT4 were PCR-amplified using pK6-MenT2, 
pK6-MenT3, and pK6-MenT4 templates, respectively, and cloned 
into pGMCS using In-Fusion HD Cloning Kits (Takara Bio). Plasmid 
pGMC-MenT1 and pGMC-MenT1-His were obtained following PCR 
amplification of menT1 and menT1-His using pK6-MenT1 as a tem-
plate and homologous recombination in linearized pGMCS plasmid by 
In-Fusion HD Cloning Kits (Takara Bio). For pGMC-*MenA4-MenT4, 
the menA4-menT4 operon was PCR-amplified from the H37Rv 
genome and cloned into linearized pGMCS plasmid by In-Fusion 
HD Cloning Kits (Takara Bio).
To construct plasmids pLAM-MenA2, pLAM-MenA3, and 
pLAM-MenA4, menA2, menA3, and menA4 were PCR-amplified using 
p29SEN-MenA2, p29SEN-MenA3, and p29SEN-MenA4 as templates, 
respectively. These were cloned as Nde I/Eco RI fragments (menA2 
and menA3) and Nde I/Mfe I fragments (menA4) into Nde I/Eco 
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RI–digested pLAM12. Plasmid p29SEN-MenA1 was used to amplify 
menA1 and menA1-His, which were then cloned as Nde I/Eco RI frag-
ments into Nde I/Eco RI–digested pLAM12 to produce pLAM-MenA1 
and pLAM-MenA1-His, respectively.
The pET vector derivatives used in this work were constructed 
as follows. To construct plasmid pET-MenT3-His, menT3-His 
(with an added fragment encoding a Ser-Ser-Gly-His6 C-terminal tag) 
was PCR-amplified from pK6-MenT3 template and cloned as an 
Nde I/Mfe I fragment into Nde I/Mfe I–digested pETDuet-1. Plasmid 
pET-MenT3-His was used as a template to construct pET-MenT3-His(D80A) 
and pET-MenT3-His(K189A) by QuikChange site-directed mutagenesis 
(Agilent) using appropriate primers. Plasmid pET-MenA3-His, 
encoding an N-terminal His6-tagged MenA3 antitoxin, was con-
structed by PCR amplification of menA3-His using p29SEN-MenA3 
as a template, Nde I/Hind III digestion, and cloning into Nde I/
Hind III–digested pET15b plasmid. To construct plasmid pET-MenT3/
MenA3-His, menA3-His was first PCR-amplified from p29SEN- MenA3 
template and cloned as an Nco I/Hind III fragment into Nco I/Hind 
III–digested pETDuet-1. menT3 was then PCR-amplified from 
pK6-MenT3, digested with Nde I/Mfe I, and cloned into Nde I/Mfe 
I–digested pET-MenA3-His. To construct pET-MenT3-His/MenA3, 
menA3 was first PCR-amplified using p29SEN-MenA3 as a template 
and cloned as an Nco I/Hind III fragment into Nco I/Hind III–digested 
pET-MenT3-His. To generate pET-MenT1-His (expressing MenT1 with 
an N-terminal His6-Ser-Ser-Gly-tag), menT1-His was PCR-amplified 
from pK6-MenT1 and cloned as an Nde I/Mfe I fragment into Nde 
I/Mfe I–digested pETDuet-1. For pET-MenA1-His (expressing MenA1 
with an N-terminal His6-Ser-Ser-Gly-tag), menA1-His was PCR- 
amplified from p29SEN-MenA1 template and cloned as an Nco I/
Bam HI fragment into Nco I/Bam HI–digested pETDuet-1. For 
pET-MenT1/MenA1-His, menT1 was PCR-amplified from pK6-MenA1 
and cloned as an Nde I/Mfe I fragment into Nde I/Mfe I–digested 
pET-MenA1-His. For pET-MenT1-His/MenA1, menA1 was PCR-amplified 
from p29SEN-MenA1 and cloned as an Nco I/Bam HI fragment into 
Nco I/Bam HI–digested pET-MenT1His.
To generate MenT3 and MenT4 expression constructs for crystal-
lization and biochemistry, overlap PCRs were performed to fuse a 
sentrin protease (SENP)–cleavable N-terminal His6-SUMO tag, 
amplified from the pBAT4 derivative (45), pSAT1-LIC (this study), 
to either menT3 or menT4, amplified from H37Rv genomic DNA. 
The resulting PCR products were cloned as either Kpn I/Hind III 
fragments into Kpn I/Hind III–digested pBAD30 (menT3), producing 
pTRB517, or as Xma I/Hind III fragments into Xma I/Hind III–
digested pBAD30 (menT4) to generate pTRB544.
Plasmids pPF656 and pPF657 were constructed by amplifying 
menA3 and menT3 from H37Rv genomic DNA and cloning as Mfe 
I/Xma I fragments into Eco RI/Xma I–digested pTA100 and pBAD30, 
respectively. To express His6-SUMO-tagged MenT3(D80A), site-directed 
mutagenesis was carried out using pTRB517 as a template. Briefly, 
nonoverlapping inverse primers were used to amplify menT3(D80A), 
followed by incubation with a mix of T4 DNA ligase, T4 polynucleotide 
kinase, and DpnI at 37°C to remove template and circularize ampli-
fied DNA. This reaction was then used to transform E. coli DH5, 
resulting in pTRB593. Similarly, this method was used to generate 
MenT3(D80A), MenT3(K189A), and MenT3(D211A) for functional testing, 
using pPF657 as a template, resulting in pTRB591, pTRB562, and 
pTRB592, respectively.
Plasmid pTRB491 was generated by amplifying menA3 from 
H37Rv genomic DNA and cloning into pSAT1-LIC via ligation- 
independent cloning (LIC). The pSAT1-LIC plasmid features a LIC 
site that fuses an N-terminal His6-SUMO tag to the target protein. 
To produce MenT3(K189A) protein, the mutated gene was amplified 
from pTRB562 and similarly cloned into pTRB550 via LIC, resulting 
in pTRB577. The pTRB550 plasmid features a His6-SUMO LIC site, 
originally amplified from pSAT1-LIC and cloned as an Eco RI/
Hind III fragment into Eco RI/Hind III–digested pBAD30.
To produce plasmids for use in M. tuberculosis, menA3, menT3, 
or both genes were amplified by PCR using PrimeSTAR GXL DNA 
polymerase, with M. tuberculosis H37Rv genomic DNA as template 
and primer pairs clo-RBS1-MenA3-attB2/clo-MenA3-attB3, clo-RBS1- 
MenT3-attB2/clo-MenT3-attB3, clo-RBS4-MenT3-attB2/clo-MenT3-
attB3, or clo-RBS1-MenA3-attB2/clo-MenT3-attB3, respectively 
(tables S1 and S2). RBS1 (AGGAAGACAGGCTGCCC) and RBS4 
(ACGAAGACAGGCTGCCC), corresponding to a strong or weak 
Shine-Dalgarno sequence, respectively, were placed upstream from 
the ATG translation start of MenA3 or the GTG translation start of 
MenT3. Plasmids pGMCS-TetR-P1-RBS1-MenA3, pGMCS-TetR-
P1-RBS1-MenA3-MenT3, pGMCS-TetR-P1-RBS1-MenT3, or pGMCS- 
TetR-P1-RBS4-MenT3 were constructed by multisite gateway 
recombination (18), using plasmid pDE43-MCS as the destination 
vector. These plasmids are integrative vectors (insertion at the attL5 
mycobacteriophage insertion site in the glyV tRNA gene) and express 
MenA3, MenT3, or MenA3-MenT3 under the control of P1 (Pmyc1 tetO), 
a tetracycline-inducible promoter (table S2) (46).
Construction of MenT3 D80A, D211A, and K189A substitutions 
for use in M. tuberculosis was performed as follows: Plasmid 
pGMCS-TetR-P1-RBS4-MenT3 was amplified by PCR with PrimeSTAR 
GXL DNA polymerase and the oligonucleotides pairs InFus- 
MenT3D80A-right/InFus-MenT3D80A-left, InFus-MenT3D211A-right/
InFus-MenT3D211A-left, or InFus-MenT3K189A-right/InFus- 
MenT3K189A-left (table S1). The amplified linear fragments were 
purified on agarose gels and circularized using the In-Fusion HD 
Cloning Kit (Takara), as recommended by the manufacturer. Plasmids 
used to transform Stellar recipient cells were verified by sequencing and 
introduced by electroporation into M. tuberculosis ∆(menA3-menT3)::dif6/
pGMCZ (see the next paragraph).
Construction of M. tuberculosis mutants
Mutant strains of M. tuberculosis H37Rv were constructed by allelic 
exchange using recombineering (43), as previously described (fig. 
S2) (47). Two ~0.5-kb DNA fragments flanking the menA3-menT3 
operon were amplified by PCR using PrimeSTAR GXL DNA 
polymerase (Takara), M. tuberculosis H37Rv genomic DNA, and the 
primer pairs MenA3Am-For/MenA3Zc-Am-Rev or MenT3Zc-Av-
For/MenT3Av-Rev, respectively (table S1). A three-fragment PCR 
fused these two fragments to a Zc-resistance cassette flanked by two 
dif6 variants of the M. tuberculosis dif site and the recombination 
substrate was recovered by agarose gel purifications. The recipient 
strain for recombineering was a derivative of M. tuberculosis H37Rv 
carrying two plasmids: pJV53H, an Hm-resistant pJV53-derived 
plasmid expressing recombineering enzymes (43), and the integra-
tive plasmid pGMCS-P1-MenA3, constitutively expressing menA3 
(table S2). This strain was grown in complete 7H9 medium supple-
mented with Hm until mid-log phase and expression of recombi-
neering enzymes was induced by Ace (0.2%) overnight at 37°C. 
After induction, electrotransformation was performed with 100 ng of 
the linear DNA fragment for allelic exchange. After a 48-hour incu-
bation at 37°C, mycobacteria were plated onto agar supplemented 
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with Zc. Zc-resistant clones were restreaked on the same medium, 
grown in complete 7H9 without antibiotic, and verified to be 
carrying the expected allele replacement by PCR amplification of 
chromosomal DNA and subsequent DNA sequencing, using 
primers MenA3Am-For/MenT3Av-Rev (fig. S1C and table S1). 
Spontaneous loss of the Zc-resistance cassette by XerCD-dependent 
recombination and of the pJV53H plasmid was obtained by serial 
rounds of culture without antibiotics and phenotypic tests for ZcS 
and HmS. Plasmid pGMCS-P1-MenA3 was then removed by trans-
formation with pGMCZ, a similar integrative vector but carrying 
resistance to Zc, resulting in the deleted strain M. tuberculosis 
∆(menA3-menT3)::dif6/pGMCZ.
E. coli multicopy plasmid library
E. coli MC4100 ∆dnaKdnaJ::KmR ∆tig:CmR double mutant (40) was 
partially digested with Sau3 AI restriction enzyme and DNA frag-
ments of about 1.5 to 4 kb in size were purified, then ligated into 
linearized and dephosphorylated Bam HI–digested pMPM2 (ColE1 
origin) plasmid (39), and used to transform E. coli DH10B. About 
25,000 independent transformants were pooled to constitute the 
multicopy library. This library has previously been used as a tool to 
identify multicopy suppressors of chaperone mutants (48).
Bacterial growth assays
In vivo toxicity and antitoxicity assays by cognate or noncognate 
antitoxins in E. coli were performed as follows. E. coli DLT1900 were 
cotransformed with pMPMK6-vector, pK6-MenT1, -MenT2, -MenT3, 
or -MenT4 (toxins), and p29SEN-vector, p29SEN-MenA1, -MenA2, -MenA3, 
or -MenA4 (antitoxins). Transformants were re-seeded from over-
night cultures and grown at 37°C to mid-log phase in LB supple-
mented with Km and Ap, and then serially diluted and spotted on 
LB-agar plates supplemented with Km and Ap, with or without 
l-ara (0.1%) and/or IPTG (200 M). Plates were incubated at 37°C 
overnight and then imaged and counted. MenT3 substitutions were 
tested for toxicity in E. coli DH5 carrying pBAD30-vector, -MenT3 
WT (pPF657), -MenT3(D80A) (pTRB591), -MenT3(K189A) (pTRB562), 
or -MenT3(D211A) (pTRB592). Strains were grown to mid-log phase, 
then serially diluted, and spotted onto M9M-agar plates supplemented 
with Ap, with or without l-ara (0.1%). After a 2-day incubation at 
37°C, plates were imaged and counted.
In vivo toxicity and rescue assays by cognate or noncognate anti-
toxins in M. smegmatis were performed as follows. Cultures of mc2 
155 strain grown in LB at 37°C were cotransformed with the inte-
grative pGMC-vector, -MenT1, -MenT2, -MenT3, or -MenT4 (toxins), 
and with pLAM12-vector, pLAM-MenA1, -MenA2, -MenA3, or -MenA4 
(antitoxins). Samples were selected on LB-agar plates supplemented 
with Km and Sm for 3 days at 37°C, in the presence or absence of 
Atc (100 ng ml−1) and Ace (0.2%) for toxin and antitoxin expres-
sion, respectively. A similar procedure was applied for pGMC- 
*MenA4-MenT4 carrying the menA4-menT4 operon, with the exception 
that no cotransformation with pLAM12 derivatives or selection 
on Km was needed.
Viability staining and flow cytometry
Exponentially growing cultures [OD600 (optical density at 600 nm) 
between 0.05 and 0.2] of M. smegmatis strain mc2 155 containing 
plasmid pGMCS-TetR-P1-RBS1-MenT3 were divided in two: Half 
was left in complete 7H9 growth medium with Sm (uninduced 
cultures), while the other half was additionally treated with Atc 
(200 ng ml−1) to induce expression from the P1 promoter. For labeling 
with LIVE/DEAD BacLight (Molecular Probes) dyes, cells were 
harvested 8 hours after Atc induction. Cells were centrifuged, resus-
pended in phosphate-buffered saline buffer, and stained as 
recommended by the manufacturer. Labeled cells were analyzed by 
fluorescence-activated cell sorting using a BD LSRFortessa X20 flow 
cytometer. Flow cytometry data analysis was performed using 
FlowJo software.
Toxicity assays in M. tuberculosis
M. tuberculosis strains H37Rv or H37Rv ∆(menA3-menT3)::dif6/
pGMCZ were transformed by electroporation with 100 ng of plasmids 
pGMCS-TetR-P1-RBS1-MenA3, pGMCS-TetR-P1-RBS1-MenA3-
MenT3, pGMCS-TetR-P1-RBS1-MenT3, pGMCS-TetR-P1-RBS4-MenT3, 
pGMCS-TetR-P1-RBS4-MenT3(D80A), pGMCS-TetR-P1-RBS4-
MenT3(K189A), or pGMCS-TetR-P1-RBS4-MenT3(D211A). After 
3 days of phenotypic expression in 7H9 ADC Tween at 37°C, the 
transformation mix was divided into two halves. One half was plated 
on 7H11 OADC with Sm; the other half was plated on 7H11 OADC 
Sm supplemented with Atc (200 ng ml−1). Plates were imaged after 
20 days of incubation at 37°C.
In vivo coaffinity purification assays
To perform in vivo copurification assays, E. coli BL21 ∆slyD was 
transformed with (i) pET-MenT3-His, pET-MenA3-His, pET-MenT3/
MenA3-His, or pET-MenT3-His/MenA3, or with (ii) pET-MenT1-His, 
pET-MenA1-His, pET-MenT1/MenA1-His, or pET-MenT1-His/MenA1, 
and selected on LB-agar plates supplemented with Ap and glu 
(20%). Transformants were grown at 37°C to an OD600 of approxi-
mately 0.4 and then protein expression was induced overnight at 
20°C with 1 mM IPTG. Cell lysis and affinity purification of the 
protein complexes were performed as described below for MenT3-His 
purification. Elution fractions were separated on SDS-PAGE and 
proteins revealed using InstantBlue Protein Stain (Expedeon, catalog 
no. ISB1L).
Recombinant protein production
To purify MenT3 for biochemistry, BL21 (DE3) ∆slyD transformed 
with pET-MenT3-His, pET-MenT3-His(D80A), or pET-MenT3-His(K189A) 
was grown to an OD600 of approximately 0.4 at 37°C. IPTG (1 mM) 
was then added, and the culture was incubated overnight at 20°C. 
Under such conditions, MenT3 expression in E. coli was better 
tolerated and led to a reasonable amount of soluble MenT3 that 
could be collected for purification. Cultures were centrifuged at 
5000g for 10 min at 4°C, pellets were resuspended in Lysis buffer 
[300 mM NaCl, 50 mM tris (pH 7.5), and protease inhibitor tablet 
(Roche); 20 ml of buffer per 1 liter of cell culture] and incubated for 
30 min on ice. Lysis was performed using the One Shot cell disrupter 
at 1.5 kbar (One Shot model, Constant Systems Ltd.). Lysates were 
centrifuged for 30 min at 30,000g in 4°C, and the resulting super-
natants were gently mixed at 4°C for 30 min with Ni–nitrilotriacetic 
acid agarose beads (Qiagen, catalog no. 30230) preequilibrated with 
buffer PD [300 mM NaCl and 50 mM tris (pH 7.5)], using a 10-ml 
poly-prep column (Bio-Rad, catalog no. 7311550). Columns were 
stabilized for 10 min at 4°C and washed three times with 10 ml of 
buffer PD plus 25 mM imidazole, and proteins were then eluted 
with buffer PD containing 250 mM imidazole. Elutions (500 l) 
were collected and PD MiniTrap G-25 columns (GE Healthcare, 
catalog no. 16924748) were used to exchange buffer with buffer PD 
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supplemented with 10% glycerol. Proteins were concentrated using 
Vivaspin 6 columns with a 5000-Da cutoff (Sartorius, catalog 
no. 184501257). Proteins were stored at −80°C until further use.
For additional MenT3 and MenT3(K189A) expression, either for 
crystallization or biochemistry, E. coli ER2566 pRARE pPF656 
was transformed with either pTRB517 or pTRB577, respectively. 
For MenT3(D80A) expression, E. coli ER2566 pRARE was transformed 
with pTRB593. MenT4 was expressed in E. coli BL21 (DE3) trans-
formed with pTRB544. MenA3 was expressed in E. coli ER2566 
transformed with pTRB491. For these expressions, the same procedure 
was followed: Overnight cultures were re-seeded 1:100 into 2-liter 
flasks containing 1-liter 2× YT. Cells were grown at 175 rpm in 
37°C until an OD600 of 0.3 was reached and then at 22°C until OD600 
0.5, whereupon expression was induced by the addition of l-ara 
(0.1%) for toxins and IPTG (1 mM) for antitoxins. Cells were left to 
grow overnight at 16°C, shaking at 175 rpm.
For selenomethionine incorporation, starter cultures of ER2566 
pRARE pPF656 pTRB517 were grown overnight in LB at 37°C with 
200 rpm shaking. Cells were pelleted, washed, and resuspended in M9M, 
and then sub-cultured into 500 ml of M9M in 2-liter baffled flasks 
to a starting OD600 of 0.075. Cells were grown at 37°C with 175 rpm 
shaking until an OD600 of 0.6, whereupon cells were centrifuged at 4200g 
and resuspended in fresh M9M. This sample was divided between 
separate 2-liter baffled flasks containing new M9M and shaken at 
175 rpm for a further 1 hour at 37°C. Once an OD600 of 0.7 was reached, 
12 ml of nutrient mix [l-lysine hydrate (4 mg ml−1), l-threonine (4 mg ml−1), 
l-phenylalanine (4 mg ml−1), l-leucine (2 mg ml−1), l-isoleucine 
(2 mg ml−1), l-valine (2 mg ml−1), and 4 mM CaCl2] was added to 
each flask to promote feedback inhibition of methionine synthesis, 
followed by 250× SelenoMethionine Solution (Molecular Dimensions) 
to a final concentration of 40 g ml−1, and cells were left to incubate 
for 1 hour at 20°C. Last, toxin and antitoxin expression were induced 
by the addition of l-ara (0.1%) and IPTG (1 mM), and samples 
were left to grow overnight at 175 rpm in 16°C.
All five proteins were purified in the same manner. Bacteria 
were harvested by centrifugation at 4200g, and the pellets were 
resuspended in buffer A500 [20 mM tris-HCl (pH 7.9), 500 mM NaCl, 
5 mM imidazole, and 10% glycerol]. Cells were lysed by sonication 
at 40 kpsi and then centrifuged (45,000g, 4°C). The clarified lysate 
was next passed over a HisTrap HP column (GE Healthcare), washed 
for 10 column volumes with A500, followed by 10 column volumes 
of buffer A100 [20 mM tris-HCl (pH 7.9), 100 mM NaCl, 5 mM 
imidazole, and 10% glycerol], and then eluted directly onto a HiTrap 
Q HP column (GE Healthcare) with buffer B100 [20 mM tris-HCl 
(pH 7.9), 100 mM NaCl, 250 mM imidazole, and 10% glycerol]. The 
Q HP column was transferred to an Äkta Pure (GE Healthcare), 
washed with 3 column volumes of A100, and then proteins were 
eluted using a gradient from 100% A100 to 100% buffer C1000 [20 mM 
tris-HCl (pH 7.9), 1000 mM NaCl, and 10% glycerol]. Fractions 
containing the protein peak were analyzed by SDS-PAGE, pooled, 
and incubated overnight at 4°C with hSENP2 SUMO protease to 
cleave the His6-SUMO tag from the target protein. The following day, 
the samples were passed through a second HisTrap HP column and 
the flow-through fractions containing untagged target protein were 
collected. These samples were concentrated and run over a HiPrep 
16/60 Sephacryl S-200 size exclusion column (GE Healthcare) in 
buffer S [50 mM tris-HCl (pH 7.9), 500 mM KCl, and 10% glycerol]. 
Peak fractions were analyzed by SDS-PAGE, pooled, and concentrated. 
Optimal fractions were separated and either flash-frozen in liquid 
N2 for storage at −80°C or dialyzed overnight at 4°C into buffer X 
[20 mM tris-HCl (pH 7.9), 150 mM NaCl, and 2.5 mM dithiothreitol 
(DTT)] for crystallographic studies. Crystallization samples were 
quantified and stored on ice and then either used immediately or 
flash-frozen in liquid N2 for storage at −80°C. Frozen crystallization 
samples still formed usable crystals 15 months after storage.
Protein crystallization
Native and selenomethionine-derivatized MenT3 were concentrated 
to 12 mg ml−1 and MenT4 was concentrated to 6 mg ml−1, all in buffer X 
(see above). Initial crystallization screens were performed using a 
Mosquito Xtal3 robot (TTP Labtech) to set 200:100 nl and 100:100 nl 
protein:condition sitting drops. After initial screening and optimi-
zation, both MenT3 protein samples formed thick, six-sided needles 
in condition G5 [0.2 M calcium acetate hydrate, 0.1 M tris (pH 8.5), 
and 25% w/v polyethylene glycol 2000 monomethyl ether] of Clear 
Strategy II HT-96 (Molecular Dimensions). MenT4 formed thin, six- 
sided needles in the same condition as MenT3. To harvest, 20 l of con-
dition reservoir was added to 20 l of cryo buffer [25 mM tris-HCl 
(pH 7.9), 187.5 mM NaCl, 3.125 mM DTT, and 80% glycerol] and 
mixed quickly by vortexing; an equal volume of this mixture was then 
added to the drop. After addition of cryo buffer, crystals were im-
mediately extracted using a nylon loop and flash-frozen in liquid N2.
Data collection and structure determination
Diffraction data were collected at Diamond Light Source on beamlines 
I04 (MenT3 native), I03 (MenT3 selenomethionine-derivatized), 
and I24 (MenT4 native) (Table 1). Single 360° datasets were collected 
for native MenT3 and MenT4. Two 360° datasets from MenT3 
selenomethionine-derivatized crystals measured at the selenium 
peak (0.9793 Å) were merged using iSpyB (Diamond Light Source). 
Additional MenT3 selenomethionine-derivatized datasets were col-
lected at selenium high remote (0.9641 Å) and inflection (0.9795 Å) 
wavelengths. Diffraction data were processed with XDS (49), and 
then AIMLESS from CCP4 (50) was used to corroborate the space 
groups (Table 1). The crystal structure of MenT3 was solved by MAD 
by providing the SHELX suite in CCP4 with the native and three 
anomalous MenT3 datasets. The solved starting model for MenT3 was 
built in REFMAC within CCP4. The crystal structure of MenT4 was 
solved ab initio using ARCIMBOLDO (51). Both models were then 
iteratively refined and built using PHENIX (52) and COOT (53), 
respectively. The quality of the final model was assessed using COOT 
and the wwPDB validation server. Structural figures were generated 
using PyMOL (Schrödinger). Comparison against models within 
the Protein Data Bank (PDB) was performed using DALI (25).
Genetic screen for suppressors of toxicity
The following genetic procedure was developed and applied to 
select for E. coli genes that confer resistance to the MenT3 toxin. 
E. coli strain DLT1900 was first transformed with pK6-MenT3 
(KmR) plasmid and transformants were selected at 37°C on LB-agar 
plates supplemented with Km and glu (0.2%) to repress toxin ex-
pression from the araBAD promoter of pK6-MenT3. DLT1900 con-
taining pK6-MenT3 was then grown in LB supplemented with Km 
and glu, transformed with the pMPMA2-based multicopy library of 
E. coli genes, and plated on selective LB-agar supplemented with Km, 
Ap, and l-ara (0.1%) to induce toxin expression. Plates were incu-
bated for 24 hours at 37°C. A control aliquot of transformants plated 
on nonselective plates (no l-ara) indicated that the number of 
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transformants tested during the selection procedure was approxi-
mately 60,000. Note that under such conditions, E. coli DLT1900 
pK6-MenT3 transformed with pMPMA2 empty vector did not pro-
duce any colonies on selective plates. We identified 72 toxin-resistant 
colonies that grew on selective plates after 24 hours, although they 
were smaller and translucent, indicating that growth inhibition by 
the toxin is not fully blocked by the suppressors identified. Of the 
72 toxin-resistant colonies identified, only 41 were able to grow 
in culture. Plasmids were extracted from the 41 cultures, used to 
re-transform DLT1900 pK6-MenT3, and plated as above, to validate 
growth rescue in the presence of MenT3. Of 41 clones, 18 suppressors 
passed the second round of selection and were sequenced using the 
pMPMA2-For and -Rev primers (table S1).
In vitro transcription/translation assays
Assays were performed as previously described (54). Briefly, template 
DNAs of DHFR (P0ABQ4), WaaF-Strep (P37692), and GatZ-Strep 
(P0C8J8) were used for in vitro transcription/translation coupled 
assays (PURExpress, New England Biolabs). These were performed 
according to the manufacturer’s instructions, in the presence or 
absence of the toxin. Following protein synthesis reactions of 
2 hours at 37°C, samples were separated on SDS-PAGE and visual-
ized by InstantBlue staining (DHFR) or Western blots using anti- 
Strep tag antibodies (WaaF-Strep and GatZ-Strep).
Identification of uncharged tRNAs in vivo and in vitro
Prevention of E. coli tRNATrp aminoacylation by MenT3 was monitored 
using a combination of two previously published methods (29, 55). 
E. coli BL21 (DE3) transformed with pETDuet or pET-MenT3 was 
grown at 37°C to OD600 0.1  in M9M, whereupon expression of 
MenT3 was induced with 1 mM IPTG until an OD600 of about 0.4. 
The bacterial culture (25 ml) was then kept on ice and centrifuged 
for 10 min at 5000g in 4°C. The pellet was resuspended in 0.5 ml of 
cold 0.3 M sodium acetate (pH 4.5) and 10 mM EDTA and trans-
ferred to a precooled 1.5-ml microcentrifuge tube, and 0.5 ml of phenol 
(equilibrated with the same buffer) was then added. After gentle 
pipetting, the sample was transferred into phase-lock tubes with an 
additional 400 l of cold chloroform. After 30 seconds shaking, the 
sample was first incubated on ice for 15 min and then centrifuged for 
20 min at 20,000g in 4°C. The aqueous phase was then transferred 
to a new cold 1.5-ml tube. Five hundred microliters of cold isopro-
panol was added and immediately mixed. RNA was precipitated for 
1 hour at −20°C, before the sample was centrifuged for 30 min at 
20,000g in 4°C (55). The supernatant was discarded and 1 ml of cold 
75% ethanol was carefully added without disturbing the RNA pellet. 
After further centrifugation for 10 min at 20,000g in 4°C, the super-
natant was removed and the pellet was air-dried until no ethanol 
remained. The pellet was then resuspended by vigorously mixing in 
20 l of cold 10 mM sodium acetate (pH 4.5) and 1 mM EDTA. Samples 
were stored at −80°C. Samples were separated on a denaturing urea 
acrylamide gel for 3 hours at 100 V in 4°C, as previously described 
(29). Northern blot and visualization with a radiolabeled DNA probe 
against tRNATrp was performed as previously described (56). Note 
that to distinguish the band of aminoacylated tRNA from its deacylated 
counterpart on the Northern blot, a chemically deacylated aliquot of 
RNA sample prepared from strain containing the empty vector was 
subjected to alkaline treatment. In this case, 46 l of tris-HCl (pH 9.0) 
was added to a 4-l aliquot of the RNA sample and incubated 
for 2 hours at 37°C. Fifteen microliters of 0.3 M sodium acetate at 
pH 4.5 was added and followed by 125 l of 96% ethanol. RNA was 
precipitated at −20°C for 1 hour, resuspended, and separated as 
described above.
For in vitro tRNA charging, in vitro transcription/translation assays 
were performed as above, using gatZ as DNA template. After a 2-hour 
reaction at 37°C with or without MenT3 toxin (10 M), tRNA ex-
traction, separation, and visualization were performed as described 
for the in vivo samples.
In vitro transcription of tRNAs
Labeled tRNAs were prepared by in vitro transcription of PCR templates 
containing an integrated T7 RNA polymerase promoter sequence. 
The template for E. coli tRNATrp was made by PCR amplification of 
chromosomal DNA from strain MG1655 with the primers CC2556 
and CC2557 (CC2591 for tRNATrp without CCA) (table S1). The 
oligos for M. tuberculosis tRNAs are given in table S1. The T7 RNA 
polymerase in vitro transcription reactions were performed in 25-l 
total volume, with a 5-l nucleotide mix of 2.5 mM ATP, 2.5 mM 
CTP, 2.5 mM GTP, and 60 M UTP and 2 to 4 l of 10 mCi ml−1 of 
radiolabeled UTP [-P32]. Template (0.1 to 0.2 g) was used per 
reaction with 1.5 l of rRNasin (40 U ml−1) (Promega), 5 l of 5× 
optimized transcription buffer (Promega), 2 l of T7 RNA polymerase 
(20 U ml−1), and 2.5 l of 100 mM DTT. Template DNA was re-
moved by the addition of 2 l of RQ DNase (1 U ml−1) (Promega). 
Unincorporated nucleotides were removed by G50 spin columns 
(GE Healthcare) according to the manufacturer’s instructions, in a 
final volume of 30 l. For E. coli tRNATrp, the transcript reaction 
was gel-purified on a denaturing 5% acrylamide gel and eluted in 
0.3 M sodium acetate for 4 hours overnight at 4°C. The supernatant 
was removed, ethanol-precipitated, and resuspended in 20 to 30 l 
of nuclease-free H2O.
Nucleotide transfer assays
MenT3 NTase activity was assayed in 10-l reaction volumes con-
taining 50 mM tris-HCl (pH 9.5), 10 mM MgCl2, and 2.5 mM 
rNTPs and incubated for 20 min at 37°C. Fresh, uniformly labeled 
tRNA (0.5 l) was used per assay, with different dilutions of the pro-
tein (1, 0.1, 0.01, and 0.001 mg ml−1) in 50 mM tris-HCl (pH 7.8), 
300 mM NaCl, and 10% glycerol. The 10-l reactions were 
mixed directly with 10 l of RNA loading dye (95% formamide, 1 mM 
EDTA, 0.025% SDS, xylene cyanol, and bromophenol blue), 
denatured at 90°C, and applied to 5% polyacrylamide-urea gels. The 
gel was vacuum-dried at 80°C and exposed to a PhosphorImager screen.
In vitro antitoxicity assays
The effect of MenA3 antitoxin was assayed using in vitro- 
transcribed tRNASer2 as a substrate. For the coincubation assay, 
MenT3 (5 M) and increasing molar ratios of MenA3 were incu-
bated with tRNASer2 and 2.5 mM CTP in 10-l reaction volumes 
containing 50 mM tris-HCl (pH 9.5) and 10 mM MgCl2 for 
20 min at 37°C. For the post incubation assay, the reactions were 
first incubated for 20 min at 37°C with MenT3 alone in 7-l re-
action volumes, then 3 l containing different concentrations of 
MenA3 were added, and the reactions were incubated for a further 
20 min at 37°C.
MenT3 tRNA screening
The tRNA screening was performed using 0.5 l of uniformly labeled 
M. tuberculosis tRNAs, all containing the CCA motif. The activity 
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was tested in 50 mM tris-HCl (pH 9.5), 10 mM MgCl2, and 2.5 mM 
rCTP in 10-l reaction volumes and incubated for 20 min at 37°C. 
The transcripts were incubated with 1 l of MenT3 (0.1 mg ml−1), or 
with nuclease-free water as a control. The reaction was stopped with 
10 l of RNA loading dye (95% formamide, 1 mM EDTA, 0.025% 
SDS, xylene cyanol, and bromophenol blue), denatured at 90°C, and 
applied to 5% polyacrylamide-urea gels. The gel was vacuum-dried 
at 80°C and exposed to a PhosphorImager screen.
SUPPLEMENTARY MATERIALS
Supplementary material for this article is available at http://advances.sciencemag.org/cgi/
content/full/6/31/eabb6651/DC1
View/request a protocol for this paper from Bio-protocol.
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